Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer

Oncolytic viruses with their capacity to specifically replicate in and kill tumor cells emerged as a novel class of cancer therapeutics. Rat oncolytic parvovirus (H-1PV) was used to treat different types of cancer in preclinical settings and was lately successfully combined with standard gemcitabine...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Grekova, Svitlana P., Aprahamian, Marc, Daeffler, Laurent, Leuchs, Barbara, Angelova, Assia, Giese, Thomas, Galabov, Angel, Heller, Anette, Giese, Nathalia A., Rommelaere, Jean, Raykov, Zahari
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Landes Bioscience 2011
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3280904/
https://ncbi.nlm.nih.gov/pubmed/22024742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.12.10.17678
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak